KRT17 is a marker of cervical and ovarian cancer (Bai et al., 2019; Di Fiore et al., 2022), and PGR plays a role in estrogen and progesterone signaling (Ikarashi et al., 2021; Hewitt et al., 2022). This evidence concerns the gene KRT17 and ovarian cancer.